Bilastine/Dextromethorphan Hydrobromide/Phenylephrine Hydrochloride

比拉斯汀/氢溴酸右美沙芬/盐酸去氧肾上腺素

Report date: 2025/07/31 10:53:56

Base Information

Drug NameBilastine/Dextromethorphan Hydrobromide/Phenylephrine Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsGlutamate [NMDA] receptor antagonistsAdrenergic receptor alpha-1 agonists
TargetsHistamine H1 receptorGlutamate [NMDA] receptorAdrenergic receptors alpha-1
Therapy Area/IndicationsCoughRespiratory Tract DiseasesCommon Cold
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsYes BilastineDextromethorphan HydrobromidePhenylephrine Hydrochloride
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlenmark Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGlenmark Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsCoughCommon Cold
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A